Soleno Therapeutics awaits FDA decision on its drug for Prader-Willi Syndrome, facing challenges amid Trump Administration's government changes.

Actinium Pharmaceuticals, Inc.  (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced it has entered into an agreement for the supply of Actinium-225 ...

Stocks like Reliance Industries, Apollo Hospitals Enterprise, Power Grid Corporation, Allied Blenders and Distillers, ...

Signal12 Pharmaceuticals has aligned with the FDA on its phase 3 clinical trial strategy for Pro-ocular, a novel drop-free ...

The Welnax BioClear Toenail Fungus Device is a cutting-edge, non-invasive laser therapy tool designed for at-home use. Unlike ...

Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals 4Q and full year 2024 earnings call. At this time, all lines are in a listen only mode. Following the presentation, we will ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Biologics Licensing Application (BLA) for clemidsogene lanparvovec (RGX-121) submitted and on track for potential FDA approval 2H 2025; strategic partnership with Nippon Shinyaku aims to expand ...

Drugmaker Mallinckrodt struck a deal to buy Endo in an effort to build a diversified pharmaceuticals company with a hefty U.S. footprint. The companies said Thursday they reached a definitive ...

Stocks like Tata Steel, NHPC, NTPC Green Energy, Firstsource Solutions, Coromandel International, SP Apparels, Zydus Lifesciences, Jaiprakash Associates, Rollatainers, Satin Creditcare Network, and ...

That's what Yum Brands' (YUM.N), opens new tab Taco Bell chain served up to Wall Street this week, the most recent effort by a major fast-food chain ... Operating Officer Jason Kidd showed Wall ...

Claim your 7-Day free trial now. Lexicon Pharmaceuticals Inc LXRX shares are trading lower by 42% to 40 cents Monday morning. The company earlier announced topline results from its PROGRESS Phase ...